Producibility and digestibility of antihypertensive β-casein tripeptides, Val-pro-pro and ile-pro-pro, in the gastrointestinal tract: Analyses using an in vitro model of mammalian gastrointestinal digestion

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 3, 2008, Pages 854-858

  Ohsawa, Kazuhito ^a   Satsu, Hideo ^b   Ohki, Kohji ^a   Enjoh, Masashi ^b   Takano, Toshiaki ^a   Shimizu, Makoto ^b  

^a CALPIS Co Ltd   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antihypertensive tripeptide; Casein; Gastrointestinal digestion

Indexed keywords

ANGIOTENSIN-CONVERTING ENZYME; DIGESTIVE ENZYMES; GASTROINTESTINAL DIGESTION; GASTROINTESTINAL TRACT; IN-VITRO; LACTOBACILLUS HELVETICUS; ORAL ADMINISTRATION; PEPTIDE SEQUENCES; PHYSIOLOGICAL EFFECTS; STRONG CORRELATION; TRI-PEPTIDES; TRIPEPTIDE;

ADSORPTION; CATALYSTS; COMPENSATION (PERSONNEL); ENZYMATIC HYDROLYSIS; FERMENTED MILK; MAMMALS; OCCUPATIONAL RISKS; PEPTIDES;

CASEIN;

LACTOBACILLUS HELVETICUS; MAMMALIA;

EID: 80051848862     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf072671n     Document Type: Conference Paper

References (28)

1. Meisel, H.; FitzGerald, R. J. Opioid peptides encrypted in intact milk protein sequences. Br. J. Nutr. 2000, 84 (Suppl. 1), S27-S31. (Pubitemid 32109213)
2. Teschemacher, H.; Kock, G.; Brantl, V. Milk protein-derived opioid receptor ligands. Biopolymers 1997, 43, 99-117. (Pubitemid 27291389)
3. Hayes, M.; Ross, R. P.; Fitzgerald, G. F.; Hill, C.; Stanton, C. Caseinderived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026. Appl. EnViron. Microbiol. 2006, 72, 2260-2264.
4. Lahov, E.; Regelson, W. Antibacterial and immunostimulating casein-derived substances from milk: casecidein, isracidin peptides. Food Chem. Toxicol. 1996, 34, 131-145. (Pubitemid 26060574)
5. FitzGerald, R. J.; Meisel, H. Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr. 2000, 84 (Suppl. 1), S33-S37. (Pubitemid 32106827)
6. Nakamura, Y.; Yamamoto, N.; Sakai, K.; Okubo, A.; Yamazaki, S.; Takano, T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. J. Dairy Sci. 1995, 78, 777-783.
7. Nakamura, Y.; Yamamoto, N.; Sakai, K.; Takano, T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. J. Dairy Sci. 1995, 78, 1253-1257.
8. Yamamoto, N.; Ejiri, M.; Mizuno, S. Biogenic peptides and their potential use. Curr. Pharm. Des. 2003, 9, 1345-1355. (Pubitemid 36592142)
9. Meisel, H.; Bochkelmann, W. Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties. Antonie Van Leeuwenhoek 1999, 76, 207-215. (Pubitemid 29440728)
10. Meisel, H. ; Walsh, D. J.; Murray, B.; FitzGerald, R. J. ACE Inhibitory Peptides. in Nutraceutical Proteins and Peptides in Health and Disease; Mine, Y., Shahidi, F., Eds.; CRC Press Taylor & Francis Group: Boca Raton, London, and New York, 2006; Pp 269-305.
11. Hata, Y.; Yamamoto, M.; Ohni, M.; Nakajima, K.; Nakamura, Y.; Takano, T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am. J. Clin. Nutr. 1996, 64, 767-771. (Pubitemid 26398281)
12. Seppo, L.; Kerojoki, O.; Suomalainen, T.; Korpela, R. The effect of a Lactobacillus helVeticus LBK-16 H fermented milk on hypertensionsA pilot study on humans. Milchwissenschaft 2002, 57, 124-127. (Pubitemid 34881652)
13. Mizuno, S.; Nishimura, S.; Matsuura, K.; Gotou, T.; Yamamoto, N. Release of short and proline-rich antihypertensive peptides from casein hydrolysate with an Aspergillus oryzae protease. J. Dairy Sci. 2004, 87, 3183-3188. (Pubitemid 39408453)
14. Schmelzer, C. E.; Schöps, R.; Ulbrich-Hofmann, R.; Neubert, R. H.; Raith, K. Mass spectrometric characterization of peptides derived by peptic cleavage of bovine β-casein. J. Chromatogr. A 2004, 1005, 87-92. (Pubitemid 39422446)
15. Robert, M. C.; Razaname, A.; Mutter, M.; Juillerat, M. A. Identification of Angiotensin-I-Converting Enzyme Inhibitory Peptides Derived from Sodium Caseinate Hydrolysates Produced by Lactobacillus helVeticus NCC 2765. J. Agric. Food Chem. 2004, 52, 6923-6931.
16. Hidalgo, I. J.; Raub, T. J.; Borchardt, R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 1989, 96, 736-749. (Pubitemid 19057595)
17. Howell, S.; Kenny, A. J.; Turner, A. J. A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29. Biochem. J. 1992, 284, 595-601.
18. King, D. S.; Fields, C. B.; Fields, G. B. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 1990, 36, 255-266. (Pubitemid 20293378)
19. Vermeirssen, V.; Camp, J. V.; Decroos, K.; Wijmelbeke, L. V.; Verstraete, W. The impact of fermentation and in Vitro digestion on the formation of angiotensin-I-converting enzyme inhibitory activity from pea and whey protein. J. Dairy Sci. 2003, 86, 429-438. (Pubitemid 39067130)
20. Rival, S. G.; Fornaroli, S. G.; Boeriu, C.; Wichers, H. J. Caseins and casein hydrolysates. 1. lipoxygenase inhibitory properties. J. Agric. Food Chem. 2001, 49, 287-294.
21. Abubakar, A.; Saito, T.; Kitazawa, H.; Kawai, Y.; Itoh, T. Structural analysis of new antihypertensive peptides derived from cheese whey protein by proteinase K digestion. J. Dairy Sci. 1998, 81, 3131-3138. (Pubitemid 128444864)
22. Maruyama, S.; Nakagomi, K.; Tomizuka, N.; Suzuki, H. Angiotensin I-converting enzyme inhibitor derived from an enzymatic hydrolysate of casein. II. Isolation and bradykinin-potentiating activity on the uterus and the ileum of rats. Agric. Biol. Chem. 1985, 49, 1405-1409.
23. Karaki, H.; Doi, K.; Sugano, S.; Uchiwa, H.; Sugai, R.; Murakami, U.; Takemoto, S. Antihypertensive effect of tryptic hydrolysate of milk casein in spontaneously hypertensive rats. Comp. Biochem. Physiol., Part C: Pharmacol., Toxicol. Endocrinol. 1990, 96, 367-371. (Pubitemid 20326952)
24. Umbach, M.; Teschemacher, H.; Praetorius, K.; Hirschhauser, R.; Bostedt, H. Demonstration of a beta-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. Regul. Pept. 1985, 12, 223-230. (Pubitemid 16179107)
25. Miquel, E.; Gomez, J. A.; Alegria, A.; Barbera, R.; Farre, R.; Recio, I. Identification of casein phosphopeptides released after simulated digestion of milk-based infant formulas. J. Agric. Food Chem. 2005, 53, 3426-3433. (Pubitemid 40758178)
26. Yoshikawa, M.; Fujita, H. Studies on the Optimum Conditions to Utilize Biologically Active Peptides Derived from Food Proteins. in DeVelopments in Food Engineering; Yano, T., Matsuno, R., Nakamura, K., Eds.; Blackie Academic & Professional: London, U.K., 1994; Pp 1053-1055.
27. Masuda, O.; Nakamura, Y.; Takano, T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J. Nutr. 1996, 126, 3063-3068. (Pubitemid 27023881)
28. Satake, M.; Enjoh, M.; Nakamura, Y.; Takano, T.; Kawamura, Y.; Arai, S.; Shimizu, M. Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 cell monolayers. Biosci., Biotechnol., Biochem. 2002, 66, 378-384. (Pubitemid 39251060)